Aptevo Therapeutics's total assets for Q3 2024 were $15.15M, an increase of 1.51% from the previous quarter. APVO total liabilities were $10.73M for the fiscal quarter, a 2.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.